Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03682055
Title Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Cullinan Apollo Corporation
Indications

nasopharynx carcinoma

Therapies

VK-2019

Age Groups: adult | senior
Covered Countries USA | FRA


No variant requirements are available.